CFS
VIVO

Ceros Financial Services’s Meridian Bioscience Inc VIVO Stock Holding History

Ceros Financial Services’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$274K Buy
+15,560
New +$259K 0.09% 78

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Ceros Financial Services's VIVO Position: Q1 2019 in Review

Ceros Financial Services opened a new position in Meridian Bioscience Inc (VIVO) in Q1 2019: 15,560 shares worth $274K. The stake represents 0.09% of the portfolio and ranks #78 among its holdings.

183 funds tracked by Wall St. Rank hold VIVO as of Q1 2019.

  • Ceros Financial Services held 15,560 shares of Meridian Bioscience Inc worth $274K as of Q1 2019.
  • Meridian Bioscience Inc was a new Ceros Financial Services position in Q1 2019.
  • Meridian Bioscience Inc made up 0.09% of Ceros Financial Services's portfolio in Q1 2019, its #78 holding.
  • 183 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2019.

Based on Ceros Financial Services's 13F filing for Q1 2019, filed 3 May 2019.